THIRD AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 7th, 2022 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 7th, 2022 Company Industry JurisdictionThis Third Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2023 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Mark Lappe (“Executive”).